All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Cell Type | Target | HLA | Epitope | Inquiry & Datasheet |
TCRJ-CQ366 | Anti-RAC1 (FSGEHPTV) T Cell Receptor (clone T1), Jurkat Cell Line | T lymphocyte | RAC1 | HLA-A201 | FSGEHPTV | |
TCRJ-CQ367 | Anti-RAC1 (FSGEHPTV) T Cell Receptor (clone T2), Jurkat Cell Line | T lymphocyte | RAC1 | HLA-A201 | FSGEHPTV | |
TCRJ-CQ368 | Anti-RAC1 (FSGEHPTV) T Cell Receptor (clone T3), Jurkat Cell Line | T lymphocyte | RAC1 | HLA-A201 | FSGEHPTV | |
TCRJ-CQ369 | Anti-RAC1 (FSGEHPTV) T Cell Receptor (clone T4), Jurkat Cell Line | T lymphocyte | RAC1 | HLA-A201 | FSGEHPTV | |
TCRJ-CQ370 | Anti-RAC1 (FSGEHPTV) T Cell Receptor (clone T5), Jurkat Cell Line | T lymphocyte | RAC1 | HLA-A201 | FSGEHPTV | |
TCRJ-CQ371 | Anti-RAC1 (FSGEHPTV) T Cell Receptor (clone T6), Jurkat Cell Line | T lymphocyte | RAC1 | HLA-A201 | FSGEHPTV | |
XS-0623-ZP183 | Anti-RAC1 TCR-NK Cells | TCR-NK | RAC1 |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION